Risk Model–Guided Antiemetic Prophylaxis vs Physician’s Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer-Reference-Cited by-同舟云学术

Risk Model–Guided Antiemetic Prophylaxis vs Physician’s Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer

Published:2016-02-01 Issue:2 Volume:2 Page:225
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Clemons Mark¹,Bouganim Nathaniel²,Smith Stephanie³,Mazzarello Sasha³,Vandermeer Lisa³,Segal Roanne²,Dent Susan²,Gertler Stan²,Song Xinni²,Wheatley-Price Paul²,Dranitsaris George²

Affiliation:

1. Division of Medical Oncology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada2Ottawa Hospital Research Institute, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada

2. Division of Medical Oncology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada

3. Ottawa Hospital Research Institute, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The design of studies testing the effectiveness of risk-guided care has many challenges: a scoping review addressing key considerations;Journal of Clinical Epidemiology;2023-12

2. Determining the factors affecting chemotherapy-induced nausea and vomiting in children with cancer;Journal of Pediatric Nursing;2023-11

3. Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with high‐dose cisplatin;Cancer Communications;2022-12-22

4. Mitigating acute chemotherapy-associated adverse events in patients with cancer;Nature Reviews Clinical Oncology;2022-10-11

5. Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy;Journal of Oncology Pharmacy Practice;2022-08-29